Herpes viruses and human papilloma virus in nasal polyposis and controls
dc.creator | Ioannidis D., Lachanas V.A., Florou Z., Bizakis J.G., Petinaki E., Skoulakis C.E. | en |
dc.date.accessioned | 2023-01-31T08:28:29Z | |
dc.date.available | 2023-01-31T08:28:29Z | |
dc.date.issued | 2015 | |
dc.identifier | 10.1016/j.bjorl.2015.08.010 | |
dc.identifier.issn | 18088694 | |
dc.identifier.uri | http://hdl.handle.net/11615/74031 | |
dc.description.abstract | Introduction: Chronic rhinosinusitis with nasal polyps is a multifactorial disease entity with an unclear pathogenesis. Contradictory data exist in the literature on the potential implication of viral elements in adult patients with chronic rhinosinusitis. Objective: To compare the prevalence of human herpes viruses (1-6) and Human Papilloma Virus in adult patients with chronic rhinosinusitis with nasal polyps and healthy controls. Methods: Viral DNA presence was evaluated by real-time polymerase chain reaction application to nasal polyps specimens from 91 chronic rhinosinusitis with nasal polyps patients and nasal turbinate mucosa from 38 healthy controls. Results: Epstein-Barr virus positivity was higher in nasal polyps (24/91; 26.4%) versus controls (4/38; 10.5%), but the difference did not reach significance (p= 0.06). Human herpes virus-6 positivity was lower in nasal polyps (13/91; 14.29%) versus controls (10/38; 26.32%, p= 0.13). In chronic rhinosinusitis with nasal polyps group, 1 sample was herpes simplex virus-1-positive (1/91; 1.1%), and another was cytomegalovirus-positive (1/91; 1.1%), versus none in controls. No sample was positive for herpes simplex virus-2, varicella-zoster virus, high-risk-human papilloma viruses (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) and low-risk-human papilloma viruses (6, 11). Conclusion: Differences in Epstein-Barr virus and human herpes virus-6 positivity among patients with chronic rhinosinusitis with nasal polyps and healthy controls are not statistically significant, weakening the likelihood of their implication in chronic rhinosinusitis with nasal polyps pathogenesis. © 2015 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. | en |
dc.language.iso | en | en |
dc.source | Brazilian Journal of Otorhinolaryngology | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947556730&doi=10.1016%2fj.bjorl.2015.08.010&partnerID=40&md5=a33b505c8d7d23a765d02150ef6219f0 | |
dc.subject | virus DNA | en |
dc.subject | virus DNA | en |
dc.subject | adult | en |
dc.subject | aged | en |
dc.subject | Article | en |
dc.subject | chronic rhinosinusitis | en |
dc.subject | chronic rhinosinusitis with nasal polyp | en |
dc.subject | cohort analysis | en |
dc.subject | controlled study | en |
dc.subject | cross-sectional study | en |
dc.subject | Cytomegalovirus | en |
dc.subject | diagnostic test accuracy study | en |
dc.subject | endoscopic sinus surgery | en |
dc.subject | Epstein Barr virus | en |
dc.subject | female | en |
dc.subject | herpes simplex | en |
dc.subject | Herpes simplex virus | en |
dc.subject | Herpes simplex virus 1 | en |
dc.subject | Herpes simplex virus 2 | en |
dc.subject | high risk patient | en |
dc.subject | human | en |
dc.subject | Human cytomegalovirus | en |
dc.subject | Human herpesvirus 6 | en |
dc.subject | Human papillomavirus type 11 | en |
dc.subject | Human papillomavirus type 16 | en |
dc.subject | Human papillomavirus type 18 | en |
dc.subject | Human papillomavirus type 31 | en |
dc.subject | Human papillomavirus type 33 | en |
dc.subject | Human papillomavirus type 35 | en |
dc.subject | Human papillomavirus type 45 | en |
dc.subject | Human papillomavirus type 52 | en |
dc.subject | Human papillomavirus type 58 | en |
dc.subject | Human papillomavirus type 59 | en |
dc.subject | Human papillomavirus type 6 | en |
dc.subject | major clinical study | en |
dc.subject | male | en |
dc.subject | middle aged | en |
dc.subject | nose mucosa | en |
dc.subject | nose polyp | en |
dc.subject | papillomavirus infection | en |
dc.subject | predictive value | en |
dc.subject | prevalence | en |
dc.subject | real time polymerase chain reaction | en |
dc.subject | sensitivity and specificity | en |
dc.subject | turbinate | en |
dc.subject | Varicella zoster virus | en |
dc.subject | virus strain | en |
dc.subject | Wart virus | en |
dc.subject | adolescent | en |
dc.subject | case control study | en |
dc.subject | chronic disease | en |
dc.subject | classification | en |
dc.subject | genetics | en |
dc.subject | Herpesviridae | en |
dc.subject | isolation and purification | en |
dc.subject | nose polyp | en |
dc.subject | Papillomaviridae | en |
dc.subject | prospective study | en |
dc.subject | rhinitis | en |
dc.subject | sinusitis | en |
dc.subject | virology | en |
dc.subject | young adult | en |
dc.subject | Adolescent | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Case-Control Studies | en |
dc.subject | Chronic Disease | en |
dc.subject | Cross-Sectional Studies | en |
dc.subject | DNA, Viral | en |
dc.subject | Female | en |
dc.subject | Herpesviridae | en |
dc.subject | Humans | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Nasal Mucosa | en |
dc.subject | Nasal Polyps | en |
dc.subject | Papillomaviridae | en |
dc.subject | Prospective Studies | en |
dc.subject | Real-Time Polymerase Chain Reaction | en |
dc.subject | Rhinitis | en |
dc.subject | Sinusitis | en |
dc.subject | Young Adult | en |
dc.subject | Elsevier Editora Ltda | en |
dc.title | Herpes viruses and human papilloma virus in nasal polyposis and controls | en |
dc.type | journalArticle | en |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |